Patent ID: 11891404
Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The method according to claim 8, wherein the cancer is selected from medulloblastoma, glioma, glioblastoma, ductal breast cancer, colorectal cancer, uterine cancer, stomach cancer, adenocarcinoma, small cell gastric cancer, squamous cell carcinoma, renal medullary carcinoma, acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia, plasma cell leukemia (PCL), hepatocellular carcinoma, non-small cell lung cancer, adenocarcinoma, small cell lung cancer, B-cell lymphoma, diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma, Hodgkin's lymphoma, B-cell non-Hodgkins lymphoma (NHL), T-cell NHL, cutaneous NHL, mantle cell lymphoma, Sezary syndrome, anaplastic large cell NHL (ALCL), mesothelioma, multiple myeloma, neuroblastoma, ovarian carcinoma, adenocarcinoma high grade serous and serous papillary, serous, cystadenocarcinoma, pancreatic cancer, prostate cancer, rhabdoid tumor, rhabdomyosarcoma, melanoma, mesothelioma, and chronic lymphocytic leukemia (CLL).